We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.50 | -14.29% | 15.00 | 14.00 | 16.00 | 18.95 | 14.50 | 17.50 | 155,725 | 16:07:18 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 149k | -7.14M | -0.1078 | -1.39 | 11.59M |
Hot Features
Premium
RNS Number:5299R
Celsis International PLC
31 October 2003
CELSIS INTERNATIONAL PLC
("the Company")
The Company has applied to the UK Listing Authority and the London Stock
Exchange for 80,000 ordinary shares of 1p each, which were issued pursuant to
the exercise of share options, to be admitted to the Official List, and to
trading on the London Stock Exchange. These shares will rank pari passu with the
existing ordinary shares of the Company and dealings are expected to commence on
3 November 2003.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEKFLBXXBBEFBZ
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
